National Biotechnology and Biomanufacturing Initiative

National Biotechnology and Biomanufacturing Initiative

featured image of Discover the Surprising Dual Nature of One Bacterium

Discover the Surprising Dual Nature of One Bacterium

BIOT

🔍 Researchers discover a bacterium with dual nature: harmful in hospitals, but with potential in dyeing fabrics and medicine. 🧫💉🌈

featured image of Fujifilm Invests $12B to Create Massive Biopharmaceutical Facility in North Carolina

Fujifilm Invests $12B to Create Massive Biopharmaceutical Facility in North Carolina

BIOT

📢 Fujifilm invests $1.2B to expand North Carolina CDMO, adding 8 bioreactors and becoming a top biopharmaceutical facility. 🏭💰💼🌍

featured image of Unlocking the Power of Industrial IoT in Bioprocessing

Unlocking the Power of Industrial IoT in Bioprocessing

BIOT

📰 The Industrial Internet of Things (IIoT) is revolutionizing bioprocessing, offering better control and streamlined regulatory submissions. 💪💰

featured image of Revolutionary Proteins Transform Nutrient Monitoring in Biopharma

Revolutionary Proteins Transform Nutrient Monitoring in Biopharma

BIOT

🔍 Researchers have developed a potential alternative technology for nutrient monitoring in biopharma using periplasmic binding proteins. 💡

featured image of Revolutionizing Bioprocessing with Integrated Microfluidics

Revolutionizing Bioprocessing with Integrated Microfluidics

BIOT

📝 Bioprocessing can benefit from the integration of microfluidic devices, similar to how integrated circuits transformed computing. 🌡️ Microfluidics offer advantages such as testing multiple variables quickly and using low reagent levels. 🧪 Researchers developed an integrated microfluidic device for continuous bioprocessing, allowing for the screening and optimization of multiple conditions. 🔬 The device demonstrated consistent production of green fluorescent protein (GFP) over eight days. ⏱️ Integrated microfluidic devices have the potential to revolutionize biomanufacturing with rapid screening and optimization capabilities.

featured image of AstraZeneca Acquires Amolyt Pharma for $105bn!

AstraZeneca Acquires Amolyt Pharma for $105bn!

BIOT

📢 AstraZeneca to acquire Amolyt Pharma for $1.05bn 💼💰 with $800m upfront and potential milestone payments of $250m. Amazing news for biotech in France and Europe!

featured image of IIT Madras Teams Up with Vellon Space to Revolutionize Biomanufacturing in Space

IIT Madras Teams Up with Vellon Space to Revolutionize Biomanufacturing in Space

BIOT

🚀 IIT Madras partners with Vellon Space to advance biomanufacturing in microgravity, revolutionizing cell culture in space.

featured image of Agathos Launches Game-Changing rAAV Service: Ethical Cell Line Revolutionizes Biomanufacturing

Agathos Launches Game-Changing rAAV Service: Ethical Cell Line Revolutionizes Biomanufacturing

BIOT

🔍 Agathos Biologics launches rAAV production service using AE1-BHK cell line, records first sale to Genovac. 💡✅🔬🌐

featured image of Revolutionizing Biomolecular Studies with Innovative Technologies

Revolutionizing Biomolecular Studies with Innovative Technologies

BIOT

🔍 Re-Imagining Surface Plasmon Resonance for Characterizing Biomolecular Interactions explores innovative technologies to enhance lab accessibility. 🧪💻

featured image of Revolutionizing Vaccines: Innovation and Flexibility are Vital

Revolutionizing Vaccines: Innovation and Flexibility are Vital

BIOT

🌍💉 The vaccine sector needs innovative technology and regulatory flexibility to thrive, says industry group Vaccines Europe. 💪🔬🚀✨